is tirzepatide safe for fatty liver issue Non-Alcoholic Disease (NAFLD): Nutrients, Diet, & Lifestyle Breaking Med

doi: 10.1016/S0024-3205(02)01522-9 101 PoznanskiSMSinghKRitchieTMAguiarJAFanIYPortilloALet al

For patients taking insulin or sulfonylureas, dose adjustments may be necessary to reduce hypoglycaemia risk

Biobert: a pre-trained biomedical language representation model for biomedical text mining

Data from market tracker PharmaTrac showed in terms of sales volume, semaglutide's market share has jumped in the last two months to 21% from 13%, after the company announced a steep price cut for Wegovy in November, followed by the launch of Ozempic in December at a much lower price point than Lilly's drug

For the science behind why I chose tirzepatide over semaglutide, see the tirzepatide vs semaglutide comparison